Home128940 • KRX
Hanmi Pharm Co Ltd
â‚©313,500.00
Sep 28, 6:00:00 PM GMT+9 · KRW · KRX · Disclaimer
Stock
Previous close
â‚©338,000.00
Day range
â‚©311,500.00 - â‚©333,000.00
Year range
â‚©258,000.00 - â‚©377,000.00
Market cap
4.02T KRW
Avg Volume
67.18K
P/E ratio
21.57
Dividend yield
0.16%
Market news
Financials
Income Statement
Revenue
Net income
(KRW)Jun 2024Y/Y change
Revenue
378.13B10.33%
Operating expense
148.57B1.05%
Net income
40.27B188.07%
Net profit margin
10.65161.03%
Earnings per share
——
EBITDA
82.45B42.57%
Effective tax rate
12.82%—
Total assets
Total liabilities
(KRW)Jun 2024Y/Y change
Cash and short-term investments
246.89B10.72%
Total assets
1.98T5.88%
Total liabilities
756.21B-6.81%
Total equity
1.22T—
Shares outstanding
12.68M—
Price to book
4.06—
Return on assets
7.36%—
Return on capital
8.37%—
Net change in cash
(KRW)Jun 2024Y/Y change
Net income
40.27B188.07%
Cash from operations
30.98B-30.71%
Cash from investing
-52.02B-227.42%
Cash from financing
-58.25B50.93%
Net change in cash
-78.56B-99.54%
Free cash flow
-10.52B-128.32%
About
Hanmi Pharm Co., Ltd. is a South Korean pharmaceutical company that is headquartered in Seoul. Wikipedia
Founded
1973
Employees
2,273
Search
Clear search
Close search
Google apps
Main menu